HOMEPAGE
Fully Diluted Subscribe

NYSE · Biotech stocks database

ZTS — Zoetis Inc.

ZTS (Zoetis Inc.) stock: $79.43, $32.82B market cap, $1.53B cash, $40.34B EV, $34.08B fully diluted market cap. Data from Fully Diluted's biotech stocks database.

What they do

We have a diversified business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within seven major product categories: parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical and animal health diagnostics.

Source: 10-K FY2025 via SEC EDGAR

Share price
$79.43
Market cap
$32,822.4M
Cash
$1,533.0M
Enterprise value
$40,338.4M

Balance sheet

Cash$1,533.0M
Debt$9,049.0M
Net cash-$7,516.0M
Enterprise value$40,338.4M
Basic shares406.3M shares
Fully diluted shares429.1M shares
Fully diluted market cap$34,081.2M
Cash per share$3.77
Quarterly burn+$655.0M generated

Cash figures as of 2026-09-30. Database snapshot: 2026-11-07.

Share structure

Common
413.2M
Pre-funded warrants
0.0M
Options
1.6M
RSUs
0.8M
Warrants
0.0M
Converts
13.5M
Conv preferred
0.0M
ESPP reserve
—
FDSO
429.1M

Cap table as of 2026-06-30.

Price history

Loading ZTS daily closes…

Loading price history…
Get the weekly biotech catalyst rundown.
Cash runways, financings, and trial readouts for all 721 stocks.
Subscribe to Compounding Ego